Skip to main content
Premium Trial:

Request an Annual Quote

Agilent Acquires GE Healthcare's Chemiluminescence Line to Bolster Gas Chromatographs

NEW YORK (GenomeWeb News) — Agilent Technologies has purchased the chemiluminescence product line from GE Healthcare’s Analytical Instruments segment, Agilent said today.
 
The deal includes intellectual property, sales, marketing, and manufacturing assets.
 
New products Agilent acquired through the deal include sulfur and nitrogen chemiluminescence detectors that Agilent said it will incorporate into its Chemical Analysis Solutions unit.  
 
Agilent said it will offer the products as add-ons to its gas chromatographs.
 
Financial terms of the deal were not released.

The Scan

Should've Been Spotted Sooner

Scientists tell the Guardian that SARS-CoV-2 testing issues at a UK lab should have been noticed earlier.

For Martian Fuel

Researchers have outlined a plan to produce rocket fuel on Mars that uses a combination of sunlight, carbon dioxide, frozen water, cyanobacteria, and engineered E. coli, according to Gizmodo.

To Boost Rapid Testing

The Washington Post writes that new US programs aim to boost the availability of rapid at-home SARS-CoV-2 tests.

PNAS Papers on Strawberry Evolution, Cell Cycle Regulators, False-Positive Triplex Gene Editing

In PNAS this week: strawberry pan-genome, cell cycle-related roles for MDM2 and MDMX, and more.